[{"id":"293aa130-f843-4e6e-b244-1c52e1d1dad3","acronym":"","url":"https://clinicaltrials.gov/study/NCT01324830","created_at":"2021-01-18T05:23:43.525Z","updated_at":"2024-07-02T16:37:04.485Z","phase":"Phase 1a/1b","brief_title":"Monotherapy Dose Finding With BI 847325 in Solid Tumours","source_id_and_acronym":"NCT01324830","lead_sponsor":"Boehringer Ingelheim","biomarkers":" KRAS • BRAF","pipe":" | ","alterations":" KRAS mutation • BRAF mutation • RAS mutation","tags":["KRAS • BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation • BRAF mutation • RAS mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BI 847325"],"overall_status":"Completed","enrollment":" Enrollment 69","initiation":"Initiation: 04/15/2011","start_date":" 04/15/2011","primary_txt":" Primary completion: 06/06/2013","primary_completion_date":" 06/06/2013","study_txt":" Completion: 10/10/2013","study_completion_date":" 10/10/2013","last_update_posted":"2018-12-21"}]